Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Autoimmunity and toxic agents]

L Pelletier1, M Castedo, P Druet

  • 1INSERM U28, hôpital Broussais, Paris.

La Revue Du Praticien
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaptation and Validation of a Portuguese Version of the Sports Motivation Scale-II (SMS-II-P) Showing Invariance for Gender and Sport Type.

Perceptual and motor skills·2021
Same author

Adaptation and validation of the Portuguese version of the regulation of eating behavior scale (REBSp).

Appetite·2020
Same author

Under-diagnosis of mood disorders in Canada.

Epidemiology and psychiatric sciences·2016
Same author

Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

Opposing effects of pericentrin and microcephalin on the pericentriolar material regulate CHK1 activation in the DNA damage response.

Oncogene·2015
Same author

Comparison of the estimated prevalence of mood and/or anxiety disorders in Canada between self-report and administrative data.

Epidemiology and psychiatric sciences·2015
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Certain drugs can trigger autoimmune diseases by modifying the body's own molecules, leading to immune system attacks. This can cause organ-specific or systemic conditions like hepatitis or lupus-like illnesses.

Area of Science:

  • Toxicology
  • Immunology
  • Pharmacology

Context:

  • Medicinal drugs and toxic agents can induce organ-specific or systemic diseases.
  • The mechanisms of drug-induced diseases vary based on the toxic agent.
  • Understanding these mechanisms is crucial for preventing and treating adverse drug reactions.

Purpose:

  • To explore the mechanisms by which drugs and toxic agents induce autoimmune disorders.
  • To elucidate how modification of autoantigens by xenobiotics can lead to immune-mediated diseases.
  • To discuss the role of drug-protein interactions in initiating autoimmune responses.

Summary:

  • Toxic agents can modify self-molecules (autoantigens), making them immunogenic and triggering autoimmune responses.
  • Covalent binding of drugs to enzymes can render them immunogenic, potentially causing hepatitis.

Related Experiment Videos

  • Modification of major histocompatibility complex (MHC) class II molecules can lead to polyclonal lymphocyte B activation and lupus-like disease.
  • Drugs can also interfere with the regulation of autoreactive T cells, causing systemic autoimmune manifestations.
  • Impact:

    • Provides insights into the pathogenesis of drug-induced autoimmune diseases.
    • Highlights the importance of considering immunogenicity in drug development and safety assessment.
    • Contributes to the understanding of autoimmune disorders, potentially leading to novel therapeutic strategies.